AeroLeads people directory · profile

Jennifer E. Gerber, Phd, Msc Email & Phone Number

Epidemiologist | PhD, Vaccines Specialist | Clinical Trials | Product Safety, Effectiveness, & Access at Eliassen Group
Location: Washington DC-Baltimore Area, United States, United States 12 work roles 3 schools
1 work email found @jhsph.edu LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email j****@jhsph.edu
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Epidemiologist | PhD, Vaccines Specialist | Clinical Trials | Product Safety, Effectiveness, & Access
Location
Washington DC-Baltimore Area, United States, United States
Company size

Who is Jennifer E. Gerber, Phd, Msc? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Jennifer E. Gerber, Phd, Msc is listed as Epidemiologist | PhD, Vaccines Specialist | Clinical Trials | Product Safety, Effectiveness, & Access at Eliassen Group, a company with 1 employees, based in Washington DC-Baltimore Area, United States, United States. AeroLeads shows a work email signal at jhsph.edu and a matched LinkedIn profile for Jennifer E. Gerber, Phd, Msc.

Jennifer E. Gerber, Phd, Msc previously worked as Epidemiologist @ Walmart Healthcare Research Institute at Eliassen Group and Associate Director, Epidemiology at Gsk. Jennifer E. Gerber, Phd, Msc holds Phd, Global Disease Epidemiology And Control from Johns Hopkins Bloomberg School Of Public Health.

Company email context

Email format at Eliassen Group

This section adds company-level context without repeating Jennifer E. Gerber, Phd, Msc's masked contact details.

*@jhsph.edu
68% confidence

AeroLeads found 1 current-domain work email signal for Jennifer E. Gerber, Phd, Msc. Compare company email patterns before reaching out.

Profile bio

About Jennifer E. Gerber, Phd, Msc

I am an epidemiologist who has over a decade of experience collaborating with stakeholders to design, implement, and manage observational studies and clinical trials. This includes primary and secondary data collection from vulnerable populations during the H1N1 and COVID-19 pandemics. I have critically appraised the literature and used real world data/evidence to document burden of disease, vaccine coverage, and assess if databases are suitable for larger analyses. I am the second author on a manuscript submitted for peer review describing an enhanced safety surveillance study that met a European regulatory commitment. As the Epidemiologist Lead, I supported Safety Teams by providing background rates for adverse events and reviewing safety data from clinical trials, contributing to assessments of benefit-risk. I am experienced wroking on global, cross-functional teams within a matrix environment (example partners: Clinical Development, Medical Affairs, Regulatory Affairs, Value Evidence/HEOR, Biostatistics, and Data Scientists). My responsibilities included reviewing scientific documents, including protocols, presentations, and regulatory communications, and working with Biostatistics on Statistical Analysis Plans, informing sample size assumptions, and interpreting statistical results. I have contributed to 19 peer-reviewed articles and given 15 scientific presentations. My career has focused on infectious disease and chronic illnesses (COVID-19, influenza, human papillomavirus transmission and associated cancers, HIV, multiple sclerosis, and behavioral and mental health). I am eager to apply my skills to new therapeutica areas and passionate about using pharmacoepidemiologic methods to improve clinical development and evaluations of product safety and effectiveness.Key skills:-Thinking through the pros and cons of using specific data sources and study designs to answer research questions- Identifying nontraditional study partners to speed up study implementation- Drafting and reviewing scientific documents for internal use and regulatory communications- Public speaking- Statistical analyses (Stata)

Listed skills include Data Analysis, Epidemiology, Questionnaire Design, Statistical Modeling, and 15 others.

Current workplace

Jennifer E. Gerber, Phd, Msc's current company

Company context helps verify the profile and gives searchers a useful next step.

Eliassen Group
Eliassen Group
Epidemiologist | PhD, Vaccines Specialist | Clinical Trials | Product Safety, Effectiveness, & Access
55 Walkers Brook Drive, 6th Floor, Reading, MA 01867, us
Website
Employees
1
AeroLeads page
12 roles

Jennifer E. Gerber, Phd, Msc work experience

A career timeline built from the work history available for this profile.

Epidemiologist @ Walmart Healthcare Research Institute

Current

Reading, MA, US

  • Supporting the Medical Evidence Generation team by designing real-world evidence studies and clinical trials to improve the health and well being of pharmacy patients across the US, especially in rural areas.
  • Contributing to new business development by collaboratively working with clients to design innovative studies that meet our collectivee goals and addresss a wide array of public health needs.
May 2024 - Present

Associate Director, Epidemiology

Gsk

Brentford, Middlesex, GB

  • Oversaw epidemiologic evidence plans and real-world evidence (RWE) generation in the US and Europe for COVID-19 vaccines in preclincial and clinical development
  • Manged a contract research organization in implementing a fully-outsourced post-authorization safety study of seasonal influenza vaccines in three EU countries to meet a regulatory requirement from the European.
  • Led the epidemiologic evidence strategy and collaborated with cross-functional partners to support the global Medical Affairs and Commercial plans and strategies, regulatory documents, and work strategically how to.
  • Drafted and reviewed study protocols, statistical analysis plans, and interpreted statistical results in end of study reports and a manuscript submitted in 2024 for peer review.
  • Designed and managed burden of disease studies through systematic literature reviews and rapid data queries of medical claims databases; synthesized findings and informed vaccine development and clinical trial design.
  • Supported benefit-risk assessments by interpreting data from the peer-reviewed literature and clinical trials.
Oct 2021 - Apr 2024

Epidemiologist And Vaccine Subject Matter Expert

Research Triangle Park, NC, US

  • Served as the infectious disease and vaccine subject matter expert as part of the COVID-19 response team and as an employee of the Survey Research Division’s Center for Health Outcomes Research.
  • Obtained a contract for RTI through collaboration with former colleagues at Johns Hopkins Bloomberg School of Public Health to evaluate adult's COVID-19 vaccine-related attitudes and beliefs before and after the.
  • Supported the National Institutes of Health in administering grants to fund observational studies, clinical research, and autopsies to better understand risk factors for and the natural history of post-acute COVID-19.
  • Formed a partnership with epidemiologists and statisticians working for RTI Health Solutions and led two proposals focused on using pharmacoepidemiologic methods and real-world data to build business with the CDC..
  • Provided scientific input into RTI’s proposal to make methodologic changes to the National Health and Nutrition Examination Survey (NHANES) and helped win a multimillion-dollar contract from a 20-year-long incumbent.
Aug 2020 - Sep 2021

Temporary Consultant

Baltimore, MD, US

  • Completed work begun as a graduate student regarding the hypothetical use of genomic information to guide treatment on high-level infection units in hospitals (containment units where someone who entered the US with.
  • Conducted data analyses and served as first author on the study's publication, which reported data collected from hospital staff working at high-level infection units in the US.
May 2020 - Aug 2020

Graduate Research Assistant

Johns Hopkins Bloomberg School Of Public Health,
  • Overall Grant Title: Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease.Grant-funded Dissertation Title: The Ethical, Legal, and Social Implications of VaccinomicsFunder: The National Human.
  • Dissertation focused on 1) understanding the policy implications of using genomic data to inform vaccine development and use (vaccinomics), with the goal of improving vaccine safety and effectiveness and 2).
  • Worked on a multidisciplinary team to develop a novel survey distributed to hospital-based staff as a Graduate Research Assistant with the Berman Institute of Bioethics.
  • Acted as the project manager and developed a survey that included items from the U.S. Census and NHANES to evaluate differences between the study sample (from an online panel) and the U.S. population.
  • Adapted scales used to measure vaccine confidence among parents to also be applicable to adults without children, to include measures of vaccination behavior, and be appropriate for online administration.
  • Oversaw data collection and quality assurance; managed 4 students in assessing survey performance and data quality and a subcontractor in recruiting >1,600 respondents.
Mar 2018 - May 2020

Graduate Research Assistant

Baltimore, MD, US

  • Recruited and interviewed HPV-positive oropharyngeal cancer patients to understand the impact of diagnosis on their mental health and personal relationships (5 months, 2014).
  • Drafted grant proposals, data collection instruments, and managed the IRB process for the Vaccinomics study. Additionally interviewed respondents about their survey taking experience, revised the instrument based on.
Aug 2014 - Apr 2020

Senior Research Program Coordinator

Baltimore, MD, US

  • Project title: Human Oral Papillomavirus Transmission in Partners over Time (HOTSPOT) Study, funded by the Johns Hopkins Richard Gelb Cancer Prevention Award and the Early Detection Research Network
  • Oversaw study coordination, primary data collection, and data management at four study sites for a prospective case series of HPV-positive oropharyngeal cancer cases and their sexual partners.
  • Managed and analyzed laboratory, medical record, and survey data. Project title: Persistent Oral Human Papillomavirus Study (POPS), funded by the National Institute of Dental and Craniofacial Research
  • Managed 11 study sites in conducting a nested cohort study of oral HPV incidence and persistence in HIV-positive and high-risk adults in the U.S.
  • Ensured compliance with study protocols and assessed progress towards stratified enrollment stratified targets.
Mar 2013 - Jul 2014

Intern

Initiatives, Inc.
  • Health Care Improvement Project, funded by the United States Agency for International Development
  • Evaluated data on the effectiveness of team-based training to reduce errors in healthcare settings and inform implementation of capacity building projects.
Nov 2012 - Jan 2013

Analyst

Rockville, Maryland, US

  • Project title: Link Into Care Study, funded by the National Institute on Drug Abuse
  • Analyzed the literature on HIV/AIDS treatment and Medicaid policies affecting incarcerated populations and linkage into community-based HIV/AIDS care.
  • Drafted a conceptual framework for qualitative and quantitative data collection to evaluate how quickly formerly incarcerated populations received HIV/AIDS care after release from prison and barriers to getting.
Jun 2011 - Jul 2011

Associate Analyst

Rockville, Maryland, US

  • Designed, implemented, and managed epidemiological studies and evaluations of federally-funded public health programs. Project title: The Pregnancy and Influenza Project (PIP) and the Health Care Workers Study (HCW).
  • Served as Deputy Project Manager of two prospective cohort studies of high-risk groups’ attitudes and beliefs towards influenza vaccination and vaccine effectiveness.
  • Drafted and edited study-related materials, including protocols, recruitment scripts, data collection instruments, and training materials; worked with the CDC client to finalize documents.
  • Supervised the fielding of English and Spanish recruitment scripts and questionnaires using interactive voice response, computer-assisted telephone interviewing, and web-based administration.
  • Trained research staff in data collection methods, orally presented study procedures to the CDC client, and conducted monitoring and evaluation visits.Evaluation of Veterans Affairs Oncology and Urology Services.
  • Led web-based data collection and cleaning to evaluate the availability and quality of care at 138 Veterans Health Administration medical facilities.
Jun 2009 - Jun 2011

Research Assistant

Rockville, Maryland, US

  • Project title: Centers for Medicare and Medicaid Services Emergency Preparedness Response Inventory (CMS EPRI), funded by the Agency for Healthcare Research and Quality (AHRQ)
  • Oversaw pilot testing and evaluation of an emergency response communication platform.
  • Co-authored recommendations on how the tool could be implemented at the state or national level. Project title: Hospital Evacuation Decision Guide, funded by AHRQ
  • Synthesized data from key-informant interviews and a literature review and drafted chapter on the recommended sequence of patient evacuations.
Aug 2008 - Jun 2009

Americorps Member

Social Capital Inc. (Sci) Dorchester
Dec 2007 - Jul 2008
Team & coworkers

Colleagues at Eliassen Group

Other employees you can reach at eliassen.com. View company contacts for 1 employees →

3 education records

Jennifer E. Gerber, Phd, Msc education

Phd, Global Disease Epidemiology And Control

Johns Hopkins Bloomberg School Of Public Health

Master Of Science (Msc), Epidemiology

London School Of Hygiene And Tropical Medicine, U. Of London

Bachelor Of Arts Magna Cum Laude, Anthropology Major, Communications And Media Studies Minor

Tufts University
FAQ

Frequently asked questions about Jennifer E. Gerber, Phd, Msc

Quick answers generated from the profile data available on this page.

What company does Jennifer E. Gerber, Phd, Msc work for?

Jennifer E. Gerber, Phd, Msc works for Eliassen Group.

What is Jennifer E. Gerber, Phd, Msc's role at Eliassen Group?

Jennifer E. Gerber, Phd, Msc is listed as Epidemiologist | PhD, Vaccines Specialist | Clinical Trials | Product Safety, Effectiveness, & Access at Eliassen Group.

What is Jennifer E. Gerber, Phd, Msc's email address?

AeroLeads has found 1 work email signal at @jhsph.edu for Jennifer E. Gerber, Phd, Msc at Eliassen Group.

Where is Jennifer E. Gerber, Phd, Msc based?

Jennifer E. Gerber, Phd, Msc is based in Washington DC-Baltimore Area, United States, United States while working with Eliassen Group.

What companies has Jennifer E. Gerber, Phd, Msc worked for?

Jennifer E. Gerber, Phd, Msc has worked for Eliassen Group, Gsk, Rti International, Johns Hopkins Berman Institute Of Bioethics, and Johns Hopkins Bloomberg School Of Public Health,.

Who are Jennifer E. Gerber, Phd, Msc's colleagues at Eliassen Group?

Jennifer E. Gerber, Phd, Msc's colleagues at Eliassen Group include Rebecca Fritz Jackson, Winnie Ling, Cpa, Cgma, Zachary Hannon, Dan Jablonski, Mba, Cams, and Scott Hampoian.

How can I contact Jennifer E. Gerber, Phd, Msc?

You can use AeroLeads to view verified contact signals for Jennifer E. Gerber, Phd, Msc at Eliassen Group, including work email, phone, and LinkedIn data when available.

What schools did Jennifer E. Gerber, Phd, Msc attend?

Jennifer E. Gerber, Phd, Msc holds Phd, Global Disease Epidemiology And Control from Johns Hopkins Bloomberg School Of Public Health.

What skills is Jennifer E. Gerber, Phd, Msc known for?

Jennifer E. Gerber, Phd, Msc is listed with skills including Data Analysis, Epidemiology, Questionnaire Design, Statistical Modeling, Clinical Study Design, Research Design, Web Based Surveys, and Training.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.